Exhibition Announcement: Epistra to Exhibit at JHVS, Co-located with BioJapan
Epistra will exhibit at the “Japan Healthcare Venture Summit 2025 (JHVS)”, co-located with BioJapan 2025, held from October 8 (Wed) to 10 (Fri) at Pacifico Yokohama.
Booth Exhibits
- Epistra Accelerate — AI-powered experimental condition optimization platform
- Epistra Vision — Image analysis solution
- Epistra CFD — Computational fluid dynamics simulation supporting bioprocess scale-up
If you are facing challenges in improving research efficiency, reducing manufacturing costs, or optimizing processes based on QbD (Quality by Design), please stop by our booth.
Exhibition Highlights
- Automated optimization of experimental conditions using AI
- Integration examples with lab robots and instruments
- QbD process design support and design space prediction capabilities
- Demonstration of the cell culture-specific fluid simulator (Epistra CFD)
Exhibition Details
- Event: Japan Healthcare Venture Summit 2025 (co-located with BioJapan)
- Booth: V-56
- Dates: October 8-10, 2025
- Venue: Pacifico Yokohama, Exhibition Hall B
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.